NasdaqGS:BLLNHealthcare
BillionToOne Market Share Gains Raise Questions On Undervalued BLLN Stock
BillionToOne, listed as NasdaqGS:BLLN, is gaining market share in U.S. prenatal and oncology genetic testing, supported by its Quantitative Counting Template technology.
The company’s UNITY prenatal test, which does not require paternal DNA samples, is helping it build a substantial position in the U.S. prenatal screening market.
These developments highlight fresh business momentum that could influence how investors view BLLN within the genetic testing space.
BillionToOne focuses on blood...